The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

The AI-based system leverages advanced artificial intelligence algorithms to analyze dental radiographs with unparalleled precision.

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

A fluorescence microscopy image reveals the tuberculosis-causing bacterium Mycobacterium tuberculosis after an antimicrobial ...

Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

This innovative method significantly enhances ... approach's potential in a wider range of diseases. If successful, this innovation could lead to more effective treatments, reduced side effects ...

QFT-TB Gold Plus offers superior accuracy, reliability, and ease of use compared to traditional ... cannot spread the disease to others, but they are at risk of developing active TB if their immune ...